
Dovramilast
CAS No. 340019-69-4
Dovramilast( —— )
Catalog No. M35691 CAS No. 340019-69-4
Dovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 192 | In Stock |
![]() ![]() |
5MG | 297 | In Stock |
![]() ![]() |
10MG | 471 | In Stock |
![]() ![]() |
25MG | 877 | In Stock |
![]() ![]() |
50MG | 1371 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameDovramilast
-
NoteResearch use only, not for human use.
-
Brief DescriptionDovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor that reduces the production of pro-inflammatory mediators and cytokines.
-
DescriptionDovramilast (CC-11050) is an orally active phosphodiesterase 4 (PDE4) inhibitor and can reduce the inflammatory response and improves Isoniazid (INH)-mediated bacillary clearance from the lungs. Dovramilast, as an adjunct, is used for the research of tuberculosis (TB).
-
In Vitro——
-
In VivoDovramilast (oral gavage, 5, 25, or 50 mg/kg, single) significantly improves antibiotic-mediated bacterial killing and reduces lung pathology. Pharmacokinetic Parameters of Dovramilast in B6D2F1 mice.Animal Model:B6D2F1 mice Dosage:5, 25, or 50 mg/kg Administration:oral, 5, 25, or 50 mg/kg, single Result:Reduced PDE4 expression in mtb-infected mouse lungs.Animal Model:B6D2F1 mice Dosage:5, 25, or 50 mg/kg Administration:oral gavage, 5, 25, or 50 mg/kg, single Result:Improved antibiotic-mediated bacterial killing and reduced lung pathology.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number340019-69-4
-
Formula Weight472.55
-
Molecular FormulaC24H28N2O6S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (52.90 mM; Ultrasonic (<60°C)
-
SMILESCCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1Cc2cccc(NC(=O)C3CC3)c2C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
molnova catalog



related products
-
Mirodenafil
Mirodenafil is a PDE-5 inhibitor developed for the treatment of erectile dysfunction.The pharmacoki-netics of mirodenafil were not significantly altered by this concurrent administration. Mirodenafil (50 or 100 mg), obviously improved erectile function and was well tolerated in a representative population of Korean men with broad-spectrum ED of various etiologies and severities.
-
NSP-805
NSP-805 is a potent and selective guinea pig cardiac phosphodiesterase 3 (PDE3) inhibitor.
-
EMD57439
EMD57439 is a selective PDE-III inhibitor, showing no significant increase in c-AMP concentration and producing little change in Ca(50).